Posted on June 28, 2012
This entry was posted in General.
Say, you got a nice blog article.Really thank you! Awesome.
I appreciate you sharing this post.Really looking forward to read more. Great.
fema approved contractor
Wow, great article post.
I loved your blog article.Thanks Again. Keep writing.
fema approved contractor
Very neat article. Will read on…
I truly appreciate this blog article.Thanks Again. Cool.
Car Hire Modlin
Very good blog.Much thanks again. Awesome.
website templates for dreamweaver
Thanks again for the post.Really thank you! Really Cool.
irish handmade glass
Thank you for your article.Thanks Again. Great.
I really liked your blog article.Really thank you! Much obliged.
blog tomasza zdrowe opinie
Very informative article post. Really Great.
fix slow pc
Thanks a lot for the blog post. Want more.
Leather furniture cleaning DC
I really liked your blog post.Really looking forward to read more. Really Great.
a level chem tuition
Wow, great blog article.Thanks Again. Great.
Awesome blog.Really looking forward to read more. Keep writing.
man and van
Thanks for sharing, this is a fantastic blog. Will read on…
best 7 inch tablet
Programs Launched To Develop Medical Countermeasures Against Nuclear Threats
Concerns about terrorist attacks, the prospect of a rogue nation using nuclear weapons and the Fukushima power plant accident in Japan are fostering efforts to develop a new family of drugs that everyone hopes will never be used, according to an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world’s largest scientific society.
Ann M. Thayer, C&EN senior correspondent, explains that the federal government has launched programs to develop medical countermeasures against nuclear threats. Radiation releases can happen under various circumstances, including failure of safety systems at commercial nuclear power plants and terrorist attacks. The article describes programs run by the U.S. Food & Drug Administration (FDA), the U.S. Department of Health and Human Services and the National Institutes of Health that support several small companies as they try to develop drugs to treat acute radiation syndrome (ARS).
The article discusses the companies’ approaches. Some seek to adapt existing drugs, including treatments for the side effects of radiation therapy for cancer. Thayer notes that because these drugs are already approved by the FDA, stockpiling them would be easier. Others are looking for new compounds that can treat the symptoms of ARS or remove radioactive particles from the body.
Fill in your details below or click an icon to log in:
You are commenting using your WordPress.com account. ( Log Out / Change )
You are commenting using your Twitter account. ( Log Out / Change )
You are commenting using your Facebook account. ( Log Out / Change )
You are commenting using your Google+ account. ( Log Out / Change )
Connecting to %s
Notify me of new comments via email.
Notify me of new posts via email.